FDA approves CSL Berhings HAEGARDA
Filed with ASX · · 2 pages · English
Earlier from CSL
- CSL to Acquire Majority Stake in Chinese Plasma Fractionator
- Half Year Results Release
- Half Year Results Analysts Presentation
- FY2017 Profit Upgrade
- AFSTYLA (rFVIII-Single Chain) European Commission Approval
Later from CSL
- CSL Response to Patent Infringement Complaint
- CSL Completes Acquisition of Majority Stake in Ruide
- Appendix 4E, Directors Report and Financial Statements
- 2017 FY Results Announcement and Analysts Presentation
- CSL Behring Acquires US Biotech Company Calimmune
Follow CSL into a list and get an email when it puts out news.
Follow CSL